1. Home
  2. JAZZ
  3. JAZZ News

Latest Jazz Pharmaceuticals plc (Ireland) (JAZZ) News on September 16, 2025

JAZZ

MT Newswires

5 days ago

Amneal Pharmaceuticals Wins US FDA Approval for Generic Version of Narcolepsy Drug Xyrem

Design Therapeutics Appoints Justin Gover to Board of Directors
JAZZ

GlobeNewswire

6 days ago

Design Therapeutics Appoints Justin Gover to Board of Directors

Chronic Myelomonocytic Leukemia Market Analysis and Forecast Report 2025-2035, with Profiles of AbbVie, GlaxoSmithKline, Incyte, Jazz Pharmaceuticals, Novartis, Stemline Therapeutics, and More
JAZZ

GlobeNewswire

6 days ago

Chronic Myelomonocytic Leukemia Market Analysis and Forecast Report 2025-2035, with Profiles of AbbVie, GlaxoSmithKline, Incyte, Jazz Pharmaceuticals, Novartis, Stemline Therapeutics, and More

BofA Raises PT on Jazz Pharmaceuticals (JAZZ) to $225 From $217
JAZZ

Insider Monkey

24 days ago

BofA Raises PT on Jazz Pharmaceuticals (JAZZ) to $225 From $217

FDA cancels adcomm on Biohaven drug; Catalent lays off staff
JAZZ

BioPharma Dive

25 days ago

FDA cancels adcomm on Biohaven drug; Catalent lays off staff

Saniona Partnership and CEO Change Might Change The Case For Investing In Jazz Pharmaceuticals (JAZZ)
JAZZ

Simply Wall St.

25 days ago

Saniona Partnership and CEO Change Might Change The Case For Investing In Jazz Pharmaceuticals (JAZZ)

Jazz Pharmaceuticals to Participate in the 2025 Wells Fargo Healthcare Conference
JAZZ

PR Newswire

25 days ago

Jazz Pharmaceuticals to Participate in the 2025 Wells Fargo Healthcare Conference

Jazz Pharmaceuticals to Host Modeyso™ (dordaviprone) Investor Webcast on August 27, 2025
JAZZ

PR Newswire

a month ago

Jazz Pharmaceuticals to Host Modeyso™ (dordaviprone) Investor Webcast on August 27, 2025

JAZZ

MT Newswires

a month ago

Sector Update: Health Care Stocks Mixed Pre-Bell Wednesday

JAZZ

MT Newswires

a month ago

Jazz Pharmaceuticals Receives Global Rights to Saniona's Epilepsy Drug in More Than $1 Billion Deal

Jazz Pharmaceuticals Enters Exclusive Licensing Agreement with Saniona to Develop and Commercialize SAN2355
JAZZ

PR Newswire

a month ago

Jazz Pharmaceuticals Enters Exclusive Licensing Agreement with Saniona to Develop and Commercialize SAN2355

JAZZ

Argus Research

3 months ago

JAZZ: Raising target price to $119.00

Jazz Pharmaceuticals Releases Unexpected Phase 4 Results Highlighting Xywav®
JAZZ

Insider Monkey

3 months ago

Jazz Pharmaceuticals Releases Unexpected Phase 4 Results Highlighting Xywav®

JAZZ

Argus Research

3 months ago

JAZZ: Raising target price to $124.00

JAZZ

MT Newswires

3 months ago

Jazz Pharmaceuticals Says Zepzelca-Tecentriq Combination Gets FDA Priority Review for Lung Cancer Treatment

Zepzelca® (lurbinectedin) and Atezolizumab (Tecentriq®) Combination Granted U.S. FDA Priority Review for First-Line Maintenance Treatment of Extensive-Stage Small Cell Lung Cancer
JAZZ

PR Newswire

3 months ago

Zepzelca® (lurbinectedin) and Atezolizumab (Tecentriq®) Combination Granted U.S. FDA Priority Review for First-Line Maintenance Treatment of Extensive-Stage Small Cell Lung Cancer

JAZZ

MT Newswires

3 months ago

Jazz Pharmaceuticals Says Narcolepsy Drug Meets Primary Endpoint in Phase 4 Trial

Jazz Pharmaceuticals Presents Late-Breaking Phase 4 Data Showcasing Xywav® (calcium, magnesium, potassium, and sodium oxybates) Oral Solution Treatment Outcomes in Narcolepsy at SLEEP 2025
JAZZ

PR Newswire

3 months ago

Jazz Pharmaceuticals Presents Late-Breaking Phase 4 Data Showcasing Xywav® (calcium, magnesium, potassium, and sodium oxybates) Oral Solution Treatment Outcomes in Narcolepsy at SLEEP 2025

Why Is Jazz (JAZZ) Up 7.9% Since Last Earnings Report?
JAZZ

Zacks

3 months ago

Why Is Jazz (JAZZ) Up 7.9% Since Last Earnings Report?

Jazz Pharmaceuticals Announces Zepzelca® (lurbinectedin) and Atezolizumab (Tecentriq®) Combination Significantly Improves Survival as First-Line Maintenance Therapy for Extensive-Stage Small Cell Lung Cancer
JAZZ

PR Newswire

3 months ago

Jazz Pharmaceuticals Announces Zepzelca® (lurbinectedin) and Atezolizumab (Tecentriq®) Combination Significantly Improves Survival as First-Line Maintenance Therapy for Extensive-Stage Small Cell Lung Cancer

JAZZ

MT Newswires

3 months ago

Jazz Pharmaceuticals Says Ziihera Achieves Over 3 Years Median Overall Survival in Gastroesophageal Cancer

Jazz Pharmaceuticals Reports Clinically Meaningful Long-Term Median Overall Survival Data for Ziihera® (zanidatamab-hrii) in First-Line HER2-Positive Metastatic Gastroesophageal Adenocarcinoma at ASCO 2025
JAZZ

PR Newswire

3 months ago

Jazz Pharmaceuticals Reports Clinically Meaningful Long-Term Median Overall Survival Data for Ziihera® (zanidatamab-hrii) in First-Line HER2-Positive Metastatic Gastroesophageal Adenocarcinoma at ASCO 2025

Jazz Pharmaceuticals to Present Expansive Research Demonstrating Comprehensive Treatment Benefits of Xywav® (calcium, magnesium, potassium, and sodium oxybates) in Sleep Conditions and Associated Comorbidities at SLEEP 2025
JAZZ

PR Newswire

4 months ago

Jazz Pharmaceuticals to Present Expansive Research Demonstrating Comprehensive Treatment Benefits of Xywav® (calcium, magnesium, potassium, and sodium oxybates) in Sleep Conditions and Associated Comorbidities at SLEEP 2025

3 of Wall Street’s Favorite Stocks with Mounting Challenges
JAZZ

StockStory

4 months ago

3 of Wall Street’s Favorite Stocks with Mounting Challenges

Insiders Pour Millions into These 3 Stocks — Here’s Why They Draw Plaudits Across the Board
JAZZ

TipRanks

4 months ago

Insiders Pour Millions into These 3 Stocks — Here’s Why They Draw Plaudits Across the Board

Jazz Pharmaceuticals to Participate in Upcoming June Investor Conferences
JAZZ

PR Newswire

4 months ago

Jazz Pharmaceuticals to Participate in Upcoming June Investor Conferences

JAZZ

Argus Research

4 months ago

JAZZ: Raising target price to $122.00

JAZZ Q1 Earnings Call: Revenue and Profit Miss, Product Pipeline Drives Outlook
JAZZ

StockStory

4 months ago

JAZZ Q1 Earnings Call: Revenue and Profit Miss, Product Pipeline Drives Outlook

Jazz Pharmaceuticals' (NASDAQ:JAZZ) Earnings May Just Be The Starting Point
JAZZ

Simply Wall St.

4 months ago

Jazz Pharmaceuticals' (NASDAQ:JAZZ) Earnings May Just Be The Starting Point

JAZZ

MT Newswires

4 months ago

Jazz Pharmaceuticals Insider Bought Shares Worth $9,993,082, According to a Recent SEC Filing

Pharmaceuticals Stocks Q1 In Review: Jazz Pharmaceuticals (NASDAQ:JAZZ) Vs Peers
JAZZ

StockStory

4 months ago

Pharmaceuticals Stocks Q1 In Review: Jazz Pharmaceuticals (NASDAQ:JAZZ) Vs Peers

Unlocking Jazz (JAZZ) International Revenues: Trends, Surprises, and Prospects
JAZZ

Zacks

4 months ago

Unlocking Jazz (JAZZ) International Revenues: Trends, Surprises, and Prospects

Biotech Alert: Searches spiking for these stocks today
JAZZ

TipRanks

4 months ago

Biotech Alert: Searches spiking for these stocks today

Pharma Stock Roundup: NVO & JAZZ's Q1 Results, AZN's Pipeline Update
JAZZ

Zacks

4 months ago

Pharma Stock Roundup: NVO & JAZZ's Q1 Results, AZN's Pipeline Update

Jazz Pharmaceuticals plc Earnings Missed Analyst Estimates: Here's What Analysts Are Forecasting Now
JAZZ

Simply Wall St.

4 months ago

Jazz Pharmaceuticals plc Earnings Missed Analyst Estimates: Here's What Analysts Are Forecasting Now

JAZZ

Morningstar Research

4 months ago

Analyst Report: Jazz Pharmaceuticals plc

JAZZ

Morningstar Research

4 months ago

Analyst Report: Jazz Pharmaceuticals plc

Appeals court reverses-in-part, vacates-in part ruling in Avadel-Jazz fight
JAZZ

TipRanks

4 months ago

Appeals court reverses-in-part, vacates-in part ruling in Avadel-Jazz fight

Jazz Pharmaceuticals (JAZZ): Among Billionaire Ray Dalio’s Bridgewater’s Stock Picks with Huge Upside Potential
JAZZ

Insider Monkey

4 months ago

Jazz Pharmaceuticals (JAZZ): Among Billionaire Ray Dalio’s Bridgewater’s Stock Picks with Huge Upside Potential

JAZZ

MT Newswires

4 months ago

Morgan Stanley Cuts Price Target on Jazz Pharmaceuticals to $166 From $183, Keeps Overweight Rating

Jazz Pharmaceuticals PLC (JAZZ) Q1 2025 Earnings Call Highlights: Strong Revenue Growth Amid ...
JAZZ

GuruFocus.com

4 months ago

Jazz Pharmaceuticals PLC (JAZZ) Q1 2025 Earnings Call Highlights: Strong Revenue Growth Amid ...

JAZZ

Argus Research

4 months ago

JAZZ: Lowering target price to $122.00

Here's What Key Metrics Tell Us About Jazz (JAZZ) Q1 Earnings
JAZZ

Zacks

4 months ago

Here's What Key Metrics Tell Us About Jazz (JAZZ) Q1 Earnings

Jazz Pharmaceuticals (NASDAQ:JAZZ) Misses Q1 Sales Targets
JAZZ

StockStory

4 months ago

Jazz Pharmaceuticals (NASDAQ:JAZZ) Misses Q1 Sales Targets

Jazz Pharmaceuticals (JAZZ) Q1 Earnings and Revenues Lag Estimates
JAZZ

Zacks

4 months ago

Jazz Pharmaceuticals (JAZZ) Q1 Earnings and Revenues Lag Estimates

Jazz Pharmaceuticals Announces First Quarter 2025 Financial Results and Updates 2025 Financial Guidance
JAZZ

PR Newswire

4 months ago

Jazz Pharmaceuticals Announces First Quarter 2025 Financial Results and Updates 2025 Financial Guidance

Here's Why Jazz Pharmaceuticals (JAZZ) is a Strong Value Stock
JAZZ

Zacks

4 months ago

Here's Why Jazz Pharmaceuticals (JAZZ) is a Strong Value Stock

Earnings To Watch: Jazz Pharmaceuticals (JAZZ) Reports Q1 Results Tomorrow
JAZZ

StockStory

4 months ago

Earnings To Watch: Jazz Pharmaceuticals (JAZZ) Reports Q1 Results Tomorrow

Jazz Pharmaceuticals (JAZZ) Reports Earnings Tomorrow: What To Expect
JAZZ

StockStory

4 months ago

Jazz Pharmaceuticals (JAZZ) Reports Earnings Tomorrow: What To Expect

JAZZ

Morningstar Research

4 months ago

Analyst Report: Jazz Pharmaceuticals plc

Illumina (ILMN) Earnings Expected to Grow: Should You Buy?
JAZZ

Zacks

4 months ago

Illumina (ILMN) Earnings Expected to Grow: Should You Buy?

Jazz Pharmaceuticals to Participate in the BofA Securities 2025 Healthcare Conference
JAZZ

PR Newswire

5 months ago

Jazz Pharmaceuticals to Participate in the BofA Securities 2025 Healthcare Conference

Buy, Sell or Hold JAZZ Stock? Key Tips Ahead of Q1 Earnings
JAZZ

Zacks

5 months ago

Buy, Sell or Hold JAZZ Stock? Key Tips Ahead of Q1 Earnings

Jazz Pharmaceuticals (JAZZ) Earnings Expected to Grow: Should You Buy?
JAZZ

Zacks

5 months ago

Jazz Pharmaceuticals (JAZZ) Earnings Expected to Grow: Should You Buy?

3 Unconventional Cannabis Stocks to Watch in 2025
JAZZ

Zacks

5 months ago

3 Unconventional Cannabis Stocks to Watch in 2025

With A 14% Return On Equity, Is Jazz Pharmaceuticals plc (NASDAQ:JAZZ) A Quality Stock?
JAZZ

Simply Wall St.

5 months ago

With A 14% Return On Equity, Is Jazz Pharmaceuticals plc (NASDAQ:JAZZ) A Quality Stock?

3 Reasons to Sell JAZZ and 1 Stock to Buy Instead
JAZZ

StockStory

5 months ago

3 Reasons to Sell JAZZ and 1 Stock to Buy Instead

JAZZ

MT Newswires

5 months ago

Jazz Pharmaceuticals Receives Positive EMA Panel Opinion for Zanidatamab to Treat Biliary Tract Cancer

Jazz Pharmaceuticals Receives CHMP Positive Opinion for Zanidatamab for the Treatment of Advanced HER2-Positive Biliary Tract Cancer
JAZZ

PR Newswire

5 months ago

Jazz Pharmaceuticals Receives CHMP Positive Opinion for Zanidatamab for the Treatment of Advanced HER2-Positive Biliary Tract Cancer

Jazz Pharmaceuticals Showcases Transformative Data at ASCO 2025, Highlighting Advances in Small Cell Lung Cancer, HER2+ Gastroesophageal Cancer and Diffuse Glioma
JAZZ

PR Newswire

5 months ago

Jazz Pharmaceuticals Showcases Transformative Data at ASCO 2025, Highlighting Advances in Small Cell Lung Cancer, HER2+ Gastroesophageal Cancer and Diffuse Glioma

Buy 5 High ROE Stocks as Markets Break Tariff-Induced Losing Streak
JAZZ

Zacks

5 months ago

Buy 5 High ROE Stocks as Markets Break Tariff-Induced Losing Streak

3 Small-Cap Stocks in the Doghouse
JAZZ

StockStory

5 months ago

3 Small-Cap Stocks in the Doghouse

JAZZ

Argus Research

5 months ago

JAZZ: What does Argus have to say about JAZZ?

Jazz Pharmaceuticals to Report First Quarter Financial Results on May 6, 2025
JAZZ

PR Newswire

5 months ago

Jazz Pharmaceuticals to Report First Quarter Financial Results on May 6, 2025

JAZZ

MT Newswires

5 months ago

Jazz Pharmaceuticals Completes $935 Million Acquisition of Chimerix

Jazz Pharmaceuticals Completes Acquisition of Chimerix
JAZZ

PR Newswire

5 months ago

Jazz Pharmaceuticals Completes Acquisition of Chimerix

JAZZ vs. HRMY: Which Neuroscience Drugmaker Is the Stronger Play?
JAZZ

Zacks

5 months ago

JAZZ vs. HRMY: Which Neuroscience Drugmaker Is the Stronger Play?

JAZZ vs. ARGX: Which Stock Is the Better Value Option?
JAZZ

Zacks

5 months ago

JAZZ vs. ARGX: Which Stock Is the Better Value Option?

Why Jazz Pharmaceuticals (JAZZ) is a Top Value Stock for the Long-Term
JAZZ

Zacks

5 months ago

Why Jazz Pharmaceuticals (JAZZ) is a Top Value Stock for the Long-Term

Is Jazz Pharmaceuticals a Top Cannabis Investment for 2025?
JAZZ

Zacks

5 months ago

Is Jazz Pharmaceuticals a Top Cannabis Investment for 2025?

Pharmaceuticals Stocks Q4 In Review: Jazz Pharmaceuticals (NASDAQ:JAZZ) Vs Peers
JAZZ

StockStory

5 months ago

Pharmaceuticals Stocks Q4 In Review: Jazz Pharmaceuticals (NASDAQ:JAZZ) Vs Peers

JAZZ

Argus Research

5 months ago

JAZZ: What does Argus have to say about JAZZ?

Jazz (JAZZ) Moves 7.1% Higher: Will This Strength Last?
JAZZ

Zacks

5 months ago

Jazz (JAZZ) Moves 7.1% Higher: Will This Strength Last?

JAZZ Pharmaceuticals Stock Trades Near 52-Week Low: Time to Buy or Sell?
JAZZ

Zacks

5 months ago

JAZZ Pharmaceuticals Stock Trades Near 52-Week Low: Time to Buy or Sell?

JAZZ

Argus Research

5 months ago

JAZZ: Lowering target price to $113.00

JAZZ

Morningstar Research

5 months ago

Analyst Report: Jazz Pharmaceuticals plc

5 High ROE Stocks to Buy as Markets Face Tariff Bloodbath
JAZZ

Zacks

5 months ago

5 High ROE Stocks to Buy as Markets Face Tariff Bloodbath

JAZZ

MT Newswires

5 months ago

RBC Raises Price Target on Jazz Pharmaceuticals to $182 From $178, Keeps Outperform Rating

JAZZ

Argus Research

5 months ago

JAZZ: Lowering target price to $137.00

After a year of 4.3% returns, Jazz Pharmaceuticals plc's (NASDAQ:JAZZ) share price drop last week may have less of an impact on institutional investors
JAZZ

Simply Wall St.

5 months ago

After a year of 4.3% returns, Jazz Pharmaceuticals plc's (NASDAQ:JAZZ) share price drop last week may have less of an impact on institutional investors

JAZZ or ARGX: Which Is the Better Value Stock Right Now?
JAZZ

Zacks

6 months ago

JAZZ or ARGX: Which Is the Better Value Stock Right Now?

Is Jazz Pharmaceuticals (JAZZ) the Best Mid Cap Biotech Stock to Buy?
JAZZ

Insider Monkey

6 months ago

Is Jazz Pharmaceuticals (JAZZ) the Best Mid Cap Biotech Stock to Buy?

Jazz (JAZZ) Down 9.2% Since Last Earnings Report: Can It Rebound?
JAZZ

Zacks

6 months ago

Jazz (JAZZ) Down 9.2% Since Last Earnings Report: Can It Rebound?

Jazz Pharmaceuticals to Participate in the 24th Annual Needham Virtual Healthcare Conference
JAZZ

PR Newswire

6 months ago

Jazz Pharmaceuticals to Participate in the 24th Annual Needham Virtual Healthcare Conference

Is Jazz Pharmaceuticals plc (JAZZ) a Promising Biotech Stock According to Wall Street Analysts
JAZZ

Insider Monkey

6 months ago

Is Jazz Pharmaceuticals plc (JAZZ) a Promising Biotech Stock According to Wall Street Analysts

Why Jazz Pharmaceuticals (JAZZ) is a Top Momentum Stock for the Long-Term
JAZZ

Zacks

6 months ago

Why Jazz Pharmaceuticals (JAZZ) is a Top Momentum Stock for the Long-Term

Zacks.com featured highlights include MPLX LP, Leidos, Jazz Pharmaceuticals, Fortinet and Pilgrim's Pride
JAZZ

Zacks

6 months ago

Zacks.com featured highlights include MPLX LP, Leidos, Jazz Pharmaceuticals, Fortinet and Pilgrim's Pride

TPB, ACB and JAZZ: Three Pot Stocks Flowering With Potential Upside
JAZZ

TipRanks

6 months ago

TPB, ACB and JAZZ: Three Pot Stocks Flowering With Potential Upside

5 High ROE Stocks to Buy as Markets Dip Despite Rate Cut Hopes
JAZZ

Zacks

6 months ago

5 High ROE Stocks to Buy as Markets Dip Despite Rate Cut Hopes

Does Jazz (JAZZ) Have the Potential to Rally 38.94% as Wall Street Analysts Expect?
JAZZ

Zacks

6 months ago

Does Jazz (JAZZ) Have the Potential to Rally 38.94% as Wall Street Analysts Expect?

3 Value Stocks Skating on Thin Ice
JAZZ

StockStory

6 months ago

3 Value Stocks Skating on Thin Ice

Jazz Pharmaceuticals to Showcase Research Demonstrating Treatment Benefits of Xywav® (calcium, magnesium, potassium, and sodium oxybates) Oral Solution and Epidiolex® (cannabidiol) at American Academy of Neurology Annual Meeting
JAZZ

PR Newswire

6 months ago

Jazz Pharmaceuticals to Showcase Research Demonstrating Treatment Benefits of Xywav® (calcium, magnesium, potassium, and sodium oxybates) Oral Solution and Epidiolex® (cannabidiol) at American Academy of Neurology Annual Meeting

Cash In On The Luck Of The Irish With 5 St. Patrick's Day Stocks Near Buy Points
JAZZ

Investor's Business Daily

6 months ago

Cash In On The Luck Of The Irish With 5 St. Patrick's Day Stocks Near Buy Points

JAZZ or ILMN: Which Is the Better Value Stock Right Now?
JAZZ

Zacks

6 months ago

JAZZ or ILMN: Which Is the Better Value Stock Right Now?

Will Auvelity & Other Drugs Aid AXSM's Growth Amid Stiff Competition?
JAZZ

Zacks

6 months ago

Will Auvelity & Other Drugs Aid AXSM's Growth Amid Stiff Competition?

Here's Why Jazz Pharmaceuticals (JAZZ) is a Strong Value Stock
JAZZ

Zacks

6 months ago

Here's Why Jazz Pharmaceuticals (JAZZ) is a Strong Value Stock

JAZZ

MT Newswires

6 months ago

Jazz Pharmaceuticals Insider Sold Shares Worth $332,605, According to a Recent SEC Filing

BIIB Starts Felzartamab Phase III Study in AMR in Kidney Transplant
JAZZ

Zacks

6 months ago

BIIB Starts Felzartamab Phase III Study in AMR in Kidney Transplant

Jazz Pharmaceuticals and Boston Beer Company have been highlighted as Zacks Bull and Bear of the Day
JAZZ

Zacks

6 months ago

Jazz Pharmaceuticals and Boston Beer Company have been highlighted as Zacks Bull and Bear of the Day

Bull of the Day: Jazz Pharmaceuticals (JAZZ)
JAZZ

Zacks

6 months ago

Bull of the Day: Jazz Pharmaceuticals (JAZZ)

Share on Social Networks: